A limitation of this study is that, while we discovered that F. rodentium has dual effects via an increased anti-tumor immune response and direct tumor cell suppression in CRC, it is unclear whether F. rodentium has a greater effect on CD8+ T cells or tumor cells. The gene discussed is CD8A; the disease is neoplasm.